Skip to main content

Table 6 Incidence of liver dysfunction

From: Liver dysfunction associated with artificial nutrition in critically ill patients

 

TPN

EN

Total

p

OR (95% CI)

Overall patients

303

422

725

  

   Liver dysfunction

91 (30%)

75 (18%)

166 (23%)

0.001

1.7 (1.3–2.2)

   Cholestasis

31 (10%)

25 (6%)

56 (8%)

0.03

1.7 (1.04–2.9)

   Hepatic necrosis

28 (9%)

20 (5%)

48 (7%)

0.02

1.95 (1.1–3.4)

   Mixed pattern

56 (19%)

43 (10%)

99 (14%)

0.001

1.8 (1.3–2.6)

   Acalculous cholecystitis

1

2

3

  

Type of patients and liver dysfunction

91

75

166

  

   Medical

24 (23%)

44 (17%)

68 (19%)

0.3

1.2 (0.8–1.7)

   Surgical

55 (31%)

14 (16%)

69 (26%)

0.03

1.8 (1.02–3.1)

   Trauma

12 (52%)

17 (23%)

29 (37%)

0.02

2.1 (1.1–4)

Septic patients

122

86

208

  

   Liver dysfunction

47 (39%)

21 (24%)

68 (33%)

0.03

1.6 (1.02–2.4)

   Cholestasis

17 (14%)

6 (7%)

23 (11%)

0.1

1.9 (0.8–4.9)

   Hepatic necrosis

10 (8%)

3 (4%)

13 (6%)

0.2

2.4 (0.7–8.2)

   Mixed pattern

30 (25%)

14 (16%)

44 (21%)

0.1

1.5 (0.9–2.7)

Non-septic patients

181

336

517

  

   Liver dysfunction

44 (24%)

54 (16%)

98 (19%)

0.02

1.5 (1.06–2.2)

   Cholestasis

14 (8%)

19 (6%)

33 (6%)

0.4

1.4 (0.7–2.7)

   Hepatic necrosis

18 (10%)

17 (5%)

35 (7%)

0.04

2 (1.03–3.7)

   Mixed pattern

26 (14%)

29 (9%)

55 (11%)

0.04

1.7 (1.01–2.7)

  1. CI, confidence interval; EN, enteral nutrition; OR, odds ratio; TPN, total parenteral nutrition.